Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.
Press releases published on April 15, 2025
Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities
GlobeNewswire
·
April 15, 2025
CHAPEL-EN-LE-FRITH, United Kingdom, April 15, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences (CLS), a leading integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, today announced key strategic appointments and …
Rhombus Launches AI Search to Power Instant Security Footage Investigation and Action
GlobeNewswire
·
April 15, 2025
SACRAMENTO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Rhombus, a leader in cloud-managed physical security solutions, today announced the launch of Rhombus AI Search. The solution uses natural language processing to provide security teams with an …
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
GlobeNewswire
·
April 15, 2025
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics Cyprumed will be eligible to receive up to $493 million in upfront, development, regulatory and sales milestones INNSBRUCK, Austria, April 15, 2025 …
Echo Sets May 15 as the Global Launch Date for its Centralized Crypto Exchange
GlobeNewswire
·
April 15, 2025
Douglas, Isle of Man, April 15, 2025 (GLOBE NEWSWIRE) -- Echo, a groundbreaking centralized cryptocurrency exchange, has announced that it will officially launch globally on May 15, 2025. The much-expected event is set to be a pivotal occasion for digital …
Integral Metals Responds to China’s Rare Earth Export Restrictions, Advancing Exploration at North American Properties
GlobeNewswire
·
April 15, 2025
CALGARY, Alberta, April 15, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) recognizes the recent decision by China’s Ministry of Commerce and the General Administration of Customs to …
Orderly Launches High-Yield OmniVault for Liquidity Providers
GlobeNewswire
·
April 15, 2025
SINGAPORE, April 15, 2025 (GLOBE NEWSWIRE) -- Permissionless liquidity layer Orderly has launched OmniVault, a solution that enables everyday DeFi users to become liquidity providers (LPs) to earn high yields on their assets passively. Utilizing market- …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 15, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific …
CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions
GlobeNewswire
·
April 15, 2025
The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemes The trial is expected to enroll 250 patients to receive treatment over 36 weeks BERKELEY HEIGHTS, N.J., April 15, 2025 (GLOBE NEWSWIRE …
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
GlobeNewswire
·
April 15, 2025
Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext …
Galapagos kondigt het vertrek van haar CFO en COO, Thad Huston, aan per 1 augustus 2025
GlobeNewswire
·
April 15, 2025
Mechelen, België; 15 april 2025, 07:30 CET; gereglementeerde informatie - voorwetenschap – Galapagos NV (Euronext …
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
GlobeNewswire
·
April 15, 2025
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in …
Communiqué de presse : Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO
GlobeNewswire
·
April 15, 2025
Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO De nouvelles données de phase II démontrent l’efficacité de l’amlitélimab dans le …
Allegrow Secures $1 Million in Funding to Revolutionize Email Deliverability for B2B Companies
GlobeNewswire
·
April 15, 2025
Allegrow, an AI platform keeping B2B emails out of spam, raised $1M from Golden Section and angels including Harrison Rose (Sequoia scout). Funds will fuel product development and market growth as the company tackles email deliverability in today's AI- …
OptiCloud Introduces its Climate Tech To Help Avoid Disasters Like the Los Angeles Wildfires
GlobeNewswire
·
April 15, 2025
OptiCloud introduces an AI-powered "digital recycling" platform to combat climate change and prevent disasters like the recent California wildfires. The technology optimizes cloud infrastructure, reduces emissions, and reinvests savings into environmental …
Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering
GlobeNewswire
·
April 15, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …